Potential Environmental Reservoirs of Candida auris : A Systematic Review.
Isabel SilvaIsabel M MirandaSofia Costa de OliveiraPublished in: Journal of fungi (Basel, Switzerland) (2024)
Candida auris , a multidrug-resistant yeast, poses significant challenges in healthcare settings worldwide. Understanding its environmental reservoirs is crucial for effective control strategies. This systematic review aimed to review the literature regarding the natural and environmental reservoirs of C. auris . Following the PRISMA guidelines, published studies until October 2023 were searched in three databases: PubMed, Web of Science, and Scopus. Information regarding the origin, sampling procedure, methods for laboratory identification, and antifungal susceptibility was collected and analyzed. Thirty-three studies published between 2016 and 2023 in 15 countries were included and analyzed. C. auris was detected in various environments, including wastewater treatment plants, hospital patient care surfaces, and natural environments such as salt marshes, sand, seawater, estuaries, apples, and dogs. Detection methods varied, with molecular techniques often used alongside culture. Susceptibility profiles revealed resistance patterns. Phylogenetic studies highlight the potential of environmental strains to influence clinical infections. Despite methodological heterogeneity, this review provides valuable information for future research and highlights the need for standardized sampling and detection protocols to mitigate C. auris transmission.
Keyphrases
- wastewater treatment
- human health
- systematic review
- meta analyses
- healthcare
- candida albicans
- multidrug resistant
- life cycle
- risk assessment
- case control
- biofilm formation
- antibiotic resistance genes
- health information
- loop mediated isothermal amplification
- public health
- escherichia coli
- randomized controlled trial
- real time pcr
- emergency department
- label free
- drug resistant
- climate change
- staphylococcus aureus
- clinical practice
- current status
- pseudomonas aeruginosa
- high resolution
- adverse drug
- microbial community
- klebsiella pneumoniae
- liquid chromatography